On December 26, Johnson & Johnson (NYSE:JNJ) said it ended a mid-stage study of an experimental drug for patients with ...

As a result, finding a compatible dermatologist and solution to eczema is not just logistically difficult but often ...

For many, the festive season is marked by reunions, shared meals and long-awaited gatherings. For Mr Li, however, it often comes with apprehension. Festive periods tend to disrupt the routines that ...

The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...

Due to eczema, asthma and allergies being so closely connected, coordinated care plays a critical role in long-term outcomes. Allergists are uniquely trained to manage these conditions together rather ...

An NIH study was a beacon for the topical steroid withdrawal community. Then, amid federal upheaval, the research stalled.

A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new ...

The hardest but most important part of treating eczema is to keep skin moist to stop scratching. As soon your daughter's skin gets dry it feels itchy and she will scratch which makes it sore and dry ...

An international team of investigators led by Emma Guttman-Yassky, MD, PhD, Waldman Professor and System Chair of the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of ...